Literature DB >> 1712581

Cleavage of the HIV-1 p66 reverse transcriptase/RNase H by the p9 protease in vitro generates active p15 RNase H.

T Schulze1, M Nawrath, K Moelling.   

Abstract

The reverse transcriptase/RNase H of HIV-1 is composed of a p66/p51 heterodimer when analyzed from virus particles. A recombinant reverse transcriptase (RT)/RNase H which after purification consisted mainly of p66 was analyzed as substrate of the purified recombinant HIV-1 protease p9 in vitro. The p66 protein if treated with the protease is processed to a stable p66/p51 heterodimer. A p15 protein is a prominent cleavage product which was identified as the carboxyterminal portion of p66 by means of a monoclonal antibody. It exhibits RNase H activity when tested by activated gel analysis. Presence of SDS during the incubation allowed complete degradation of p66 depending on the conditions, which indicates that conformation of a substrate is relevant for cleavage by the HIV-1 protease. A synthetic heptapeptide AET-FYVD derived from the region between RT and RNase H is cleaved efficiently in vitro by the HIV-1 protease at the F'Y junction, and may mimick a natural cleavage site. P66/p51 heterodimers exhibit higher RT and RNase H activities than p66 when renatured from polyacrylamide gels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712581     DOI: 10.1007/bf01314028

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

1.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

2.  Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.

Authors:  V R Prasad; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Expression of biologically active human T-cell lymphotropic virus type III reverse transcriptase in Bacillus subtilis.

Authors:  S F Le Grice; V Beuck; J Mous
Journal:  Gene       Date:  1987       Impact factor: 3.688

4.  Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase.

Authors:  N Tanese; V R Prasad; S P Goff
Journal:  DNA       Date:  1988 Jul-Aug

5.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

6.  Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda.

Authors:  E Remaut; P Stanssens; W Fiers
Journal:  Gene       Date:  1981-10       Impact factor: 3.688

7.  Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes.

Authors:  D A Hager; R R Burgess
Journal:  Anal Biochem       Date:  1980-11-15       Impact factor: 3.365

8.  Reverse transcriptase and RNase H: present in a murine virus and in both subunits of an avian virus.

Authors:  K Moelling
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

9.  In vitro inhibition of HIV-1 proteinase by cerulenin.

Authors:  K Moelling; T Schulze; M T Knoop; J Kay; R Jupp; G Nicolaou; L H Pearl
Journal:  FEBS Lett       Date:  1990-02-26       Impact factor: 4.124

10.  Overproduction and preliminary crystallographic study of ribonuclease H from Escherichia coli.

Authors:  S Kanaya; A Kohara; M Miyagawa; T Matsuzaki; K Morikawa; M Ikehara
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

View more
  6 in total

1.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Characterization of HIV-1 reverse transcriptase with antibodies indicates conformational differences between the RNAse H domains of p 66 and p 15.

Authors:  A M Szilvay; S Nornes; A Kannapiran; B I Haukanes; C Endresen; D E Helland
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.

Authors:  Ryan L Slack; Justin Spiriti; Jinwoo Ahn; Michael A Parniak; Daniel M Zuckerman; Rieko Ishima
Journal:  Proteins       Date:  2015-07-01

4.  The p66 immature precursor of HIV-1 reverse transcriptase.

Authors:  Naima G Sharaf; Eric Poliner; Ryan L Slack; Martin T Christen; In-Ja L Byeon; Michael A Parniak; Angela M Gronenborn; Rieko Ishima
Journal:  Proteins       Date:  2014-05-12

5.  Detection of an RNase H activity associated with hepadnaviruses.

Authors:  S M Oberhaus; J E Newbold
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 6.  Structural Maturation of HIV-1 Reverse Transcriptase-A Metamorphic Solution to Genomic Instability.

Authors:  Robert E London
Journal:  Viruses       Date:  2016-09-27       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.